Cargando…
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
BACKGROUND: A new human myeloma cell line, MMLAL, was established from the myelomatous pleural effusion of a 73-year-old Chinese patient suffering from symptomatic International stage III IgG/lambda myeloma. After a brief period of complete remission, he developed aggressive systemic relapse complic...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866931/ https://www.ncbi.nlm.nih.gov/pubmed/24330858 http://dx.doi.org/10.1186/1475-2867-13-122 |